Alzheimer Disease, drug therapy

Name
Alzheimer Disease, drug therapy
Accession Number
DBCAT001745
Description

Not Available

Drugs
DrugDrug Description
CrenezumabCrenezumab has been used in trials studying the treatment of Alzheimer's Disease.
TricaprylinTricaprilin has been used in trials studying the supportive care and treatment of Alzheimer's Disease.
DonanemabDonanemab (LY3002813) is a humanized IgG1 monoclonal antibody targeted against an epitope at the N-terminal of a specific type of amyloid beta (Aβ) - pyroglutamate Aβ - which is found...
AducanumabA monoclonal antibody indicated in the treatment of Alzheimer's disease.
Drugs & Drug Targets
DrugTargetType
AducanumabAmyloid beta A4 proteintarget